Physician profile
Mann Trinh
NPI 1023209038
$25,701.63
in general payments reported to CMS, 2019-2025
19 companies · $5,225 in 2025
The $5,225 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $173 · 2021: $1,100 · 2022: $1,788 · 2023: $3,669 · 2024: $13K · 2025: $5,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,500 · Consulting Fee: $6,313 · Food and Beverage: $3,761 · Travel and Lodging: $3,292 · Entertainment: $220 · Gift: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,500.00 |
| Consulting Fee | $6,312.50 |
| Food and Beverage | $3,761.33 |
| Travel and Lodging | $3,291.66 |
| Entertainment | $220.22 |
| Gift | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $19,820.82 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Coopervision INC. | $1,689.78 | 2021-2025 | Myday Contact Lens |
| Topcon Healthcare, INC. | $1,348.18 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $522.44 | 2024-2025 | Xdemvy |
| Optos, INC. | $482.56 | 2020-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $283.53 | 2022-2024 | Ce-Marked Kxla System |
| Lkc Technologies, INC. | $231.28 | 2023-2025 | |
| Sight Sciences, INC. | $217.81 | 2019-2023 | Tearcare System |
| Maculogix, INC. | $182.35 | 2019-2020 | |
| Visionary Optics LLC | $175.00 | 2024 | |
| Visionix USA, INC | $154.69 | 2022 | |
| Kala Pharmaceuticals, INC. | $125.00 | 2021 | |
| Dompe US, INC. | $123.23 | 2023-2025 | Oxervate |
| Astellas Pharma US INC | $122.45 | 2025 | Izervay |
| Alcon Research LLC | $94.44 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $72.88 | 2022 | |
| Biotissue Holdings INC. | $23.74 | 2023 | |
| Bausch & Lomb Americas INC. | $18.71 | 2025 | Miebo |
| Johnson & Johnson Vision Care, INC. | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mann Trinh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.